We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg Sets as FDA Priority Flexing Enforcement Muscle
Hamburg Sets as FDA Priority Flexing Enforcement Muscle
April 23, 2010
The FDA is pursuing more flexible enforcement mechanisms and new state government partnerships to handle situations such as the recent contamination of GlaxoSmithKline’s (GSK) pediatric Rotarix vaccine, Commissioner Margaret Hamburg says.